eligard 22.5 mg powder and solvent for solution for injection
recordati industria chimica e farmaceutica spa - leuprorelin acetate - powder and solvent for solution for injection - 22.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
eligard 45 mg powder and solvent for solution for injection
recordati industria chimica e farmaceutica spa - leuprorelin acetate - powder and solvent for solution for injection - 45 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
eligard 7.5 mg powder and solvent for solution for injection
recordati industria chimica e farmaceutica spa - leuprorelin acetate - powder and solvent for solution for injection - 7.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
lutrate depot 22.5mg powder and solvent for prolonged-release suspension for injection
gp-pharm, s.a - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 22.5mg - hormones and related agents. gonadotropin-releasing hormones analogues - it is indicated for palliative treatment of hormone dependent advanced prostate cancer.
eligard 22.5 mg
kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 22.5 mg - eligard is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
eligard 45 mg
kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 45 mg - eligard is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
eligard 7.5 mg
kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 7.5 mg - eligard 7.5 mg is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer combination with radiotherapy.
eligard ® powder and solvent for solution for injection 22.5mg
dch auriga singapore - leuprorelin 20.87 mg eqv to leuprorelin acetate - injection, powder, lyophilized, for suspension,extended release - 22.5 mg - leuprorelin 20.87 mg eqv to leuprorelin acetate 22.5 mg
eligard ® powder and solvent for solution for injection 45mg
dch auriga singapore - leuprorelin 41.7 mg eqv leuprorelin acetate - injection, powder, lyophilized, for suspension,extended release - 45mg - leuprorelin 41.7 mg eqv leuprorelin acetate 45mg
eligard ® powder and solvent for solution for injection 7.5mg
dch auriga singapore - leuprorelin 6.96 mg eqv leuprorelin acetate - injection, powder, lyophilized, for suspension,extended release - 7.5 mg - leuprorelin 6.96 mg eqv leuprorelin acetate 7.5 mg